Who's Afraid Of Patent Losses? Merck, Schering, BMS Defenses Play Well
Executive Summary
Merck has regenerating brands; Schering-Plough has desloratadine; Bristol-Myers Squibb has an 11th-hour patent and a combo replacement for a major single-ingredient expiration; and they all have recession-haven reputations.